Simple is the new hard

We have a quiet agreement in this industry, and nobody signed it on purpose. It does not matter if you are a pharmaceutical company or one of their vendor partners. We have agreed that complicated means valuable. The 60-slide detail aid. The customer journey map that looks like a subway diagram. The campaign with nine messages, six channels, and four calls to action. We look at all of it and think: now that is serious work. That is worth the budget.

It is a lie. And it is costing us.

I know the pull. I have built the 60-slide deck and defended it in the room. Agencies that charge by the traditional time & materials pricing model benefit from the complexity. I have sat in the client seat and been on the vendor side... that is how I know complexity feels like safety, and why I no longer trust the feeling.

The hardest thing to do in marketing is not to add. It is to take away. Steve Jobs said it in five words: “Simple can be harder than complex.”¹  Anyone who has sat in a room trying to get a brand team to agree on one message knows exactly how hard he meant.

We confuse complicated with sophisticated

Here is the truth we don’t say out loud. People tie worth to complexity because complexity is easy to defend. A big plan justifies budget. A dense deck makes you look like you thought long and hard. A complicated campaign gives everyone in the room a line to own. Simple feels exposed. Simple feels like you didn’t earn the fee or the respect.

So we add. We add a channel because it is available. We add a message because the brand lead, market access, and legal each want their words in. We add a slide because cutting one feels like losing a fight.

The customer gets none of that. The customer gets noise.

Simple is not soft. Simple is the premium.

This is the part most people get backwards. Simplicity is not the cheap option. It is the expensive one to produce and the profitable one to own.

Siegel+Gale has measured this since 2009. Their finding: 64% of people will pay more for a simpler experience. 78% will recommend a brand because of it. They also put a number on the cost of getting it wrong: $780 billion in revenue left on the table by complex brands. And since 2009, the simplest publicly traded brands have outperformed the average global stock index by 1,600%.²

Read that again. Simple is not the safe, soft, low-ambition choice. Simple is where the money is.

Simple, yet sophisticated

The best work of our lifetime hid enormous complexity behind one easy idea.

When Apple launched the iPod, the engineering was staggering. The line was not. It was “1,000 songs in your pocket.”³No gigabytes, no specs, no jargon. A child could repeat it.

When Google launched, the homepage was a single box on a white page while every competitor was building a cluttered portal. The search algorithm behind that box was some of the hardest computer science on earth. The user only ever saw the box.

And then there is the example that should matter most to us, because it is ours.

The single-tablet regimen. Take HIV therapy. Co-formulating multiple drugs into one pill is fearsomely complex science: pharmacokinetics, stability, dosing, manufacturing. But to the patient it is one pill, once a day. That simplicity is not cosmetic. A study in AIDS Care found viral suppression in 84% of single-tablet patients after a year, versus 78% on multi-tablet regimens.⁴ Other real-world analyses link single-tablet regimens to higher adherence and fewer hospitalizations.⁵

That is the whole game in one sentence: do the hard, sophisticated work behind the curtain, and ship the customer something simple. The simplicity is the innovation.

When simplicity is embraced, everyone wins

The reward for getting this right is not subtle, and our own industry proves it right down to the message itself. When Pfizer launched Lipitor, it was the fifth statin to market, behind a field that already had three blockbusters and years of entrenched relationships. By the usual logic it was too late. But Pfizer did not try to out-claim the incumbents. It led with one idea, everywhere: Lipitor lowers bad cholesterol more. One number. One striking graph a rep could lay on the desk. Doctors and patients did not have to weigh ten claims against each other. They had to remember one. Within three years Lipitor was the top-selling statin, and it went on to become the best-selling drug in history, with more than $125 billion in sales.⁶ The competitors had more to say. Lipitor said one thing, and owned the category.

The pull toward the complicated is old. David Ogilvy named it sixty years ago: our business is full of people who try to impress “by using pretentious jargon.”⁷ Complexity, more often than not, is vanity wearing a strategy costume.

Three rules for getting to simple

Simplicity is a discipline, not a shortcut. Here is how we practice it.

1. Lead with three, and make the first one count. People hold onto three things, not ten. So give them three, and put the most important first, because the opening is what actually gets heard. This is true everywhere it matters: a rep with two minutes in a doctor’s doorway, a marketer writing a social post, a vendor pitching for the business, a new process being introduced to the field, a strategy on a page, an experience being designed. Decide what matters most. Say it first. Let two supporting points carry the rest, and stop. And never show the math unless someone asks for it. People want the answer, not the work that produced it.

2. Subtract, don’t add. Treat every channel, slide, and call to action as something you have to earn the right to keep, not something you add because you can. Saint-Exupéry’s rule is the standard: you are done when there is nothing left to take away, not when there is nothing left to add.⁸ The eighth slide, the third CTA, the fourth channel that only adds noise. Kill them.

3. Do the hard work, then hide it. The single-tablet regimen is the model. Pour the sophistication into the data, the segmentation, the science, and the analysis behind the scenes. Then give the customer something that feels effortless. Complexity is for the back office. Simplicity is for the customer.

What this means in practice

For a pharma team, simplicity is the difference between a rep who lands one message and a rep who reads the label aloud. Between a campaign people remember and a campaign people scroll past. Between a strategy the organization can actually run and a slide deck nobody can act on. None of it requires more budget. It requires the discipline to choose.

For the vendors who serve pharma, it is the whole game. When you pitch a client, you are not competing on how much you can show. You are competing on how clearly you can be understood. The partner who walks in with three sharp points, the most important one first, beats the partner who brings forty slides and a data lake. Make the buyer’s decision simple, and you are most of the way to winning it.

The bottom line

Simple is not the absence of work. It is the result of more of it. It takes longer to write the short memo, harder thinking to find the one message, and more courage to defend the plan that fits on a page.

That is the test we run on our own work at Kairos Meridian: if it cannot fit on a page, it goes back. Not the most complicated answer. The clearest one that still wins.

Simple is the new hard. So here is where to start: pick one asset this week and cut it until a single message or focal point survives. If you want a second set of eyes on what to keep, contact us at Kairos Meridian.

Kairos Meridian — big-agency thinking, boutique agility. Pharma marketing, data, and AI in service of impact.

---

Sources

1.     Steve Jobs, interview, BusinessWeek, May 25, 1998.

2.     Siegel+Gale, World’s Simplest Brands (Tenth Edition), 2023. https://www.siegelgale.com/grocery-giants-lidl-and-whole-foods-market-are-two-of-the-worlds-simplest-brands/

3.     Apple Inc., iPod introduction, October 2001.

4.     C. Hawkins et al., “Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment-naïve patients,” AIDS Care 30, no. 8 (2018). https://www.tandfonline.com/doi/full/10.1080/09540121.2018.1442554

5.     “Single- Versus Multiple-Tablet HIV Regimens: Adherence and Hospitalization Risk,” The American Journal of Managed Care. https://www.ajmc.com/view/single-versus-multiple-tablet-hiv-regimens-adherence-and-hospitalization-risk

6.     “Lipitor Becomes World’s Top-Selling Drug,” Crain’s New York Business, December 28, 2011. https://www.crainsnewyork.com/article/20111228/HEALTH_CARE/111229902/lipitor-becomes-world-s-top-selling-drug

7.     David Ogilvy, The Unpublished David Ogilvy (Profile Books, 2012).

8.     Antoine de Saint-Exupéry, Wind, Sand and Stars (1939).